Interaction Review

Good afternoon, Sandra. Thank you for joining. I understand you're preparing to start several patients on Zymorelin for adult growth hormone deficiency and wanted to review the administration protocol.

Yes, exactly. We have three patients transitioning from their current GH therapy, and I want to make sure my nursing team and I are fully prepared on the injection device and titration schedule.

Perfect. Let's start with the device itself. Zymorelin uses a pre-filled auto-injector pen that's designed for patient self-administration. The pen has an audible click that confirms the full dose has been delivered, which patients find very reassuring.

For the titration protocol, the recommended starting dose is 0.2 mg subcutaneously once daily, administered at bedtime to mimic physiological GH release patterns. After four weeks, you can titrate up by 0.1 mg increments based on IGF-1 levels and clinical response.

What's the maximum dose? And how often should we be checking IGF-1 levels during titration?

The maximum recommended dose is 0.8 mg daily. During titration, IGF-1 levels should be checked every four to six weeks. The target is to keep IGF-1 within the age- and sex-adjusted normal range, ideally in the upper half of normal. It's important not to exceed the upper limit of normal, as that increases the risk of adverse effects.

Got it. What are the most common side effects my patients should watch for?

The most frequently reported adverse events in clinical trials were peripheral edema at 18%, arthralgia at 14%, and injection site reactions at 9%. Most of these are dose-dependent and resolve with dose adjustment. I always recommend counseling patients that these effects often occur early and typically improve within the first few weeks.

That's very helpful. What about glucose monitoring? I have one patient who is pre-diabetic.

Excellent question. Growth hormone therapy can affect glucose metabolism, so for your pre-diabetic patient, I'd recommend checking fasting glucose and HbA1c at baseline, then at 3 and 6 months. Per the prescribing information, Zymorelin should be used with caution in patients with diabetes or glucose intolerance, and dose adjustments to diabetes medications may be necessary.

Should I have patients rotate injection sites?

Absolutely. Rotation is essential to prevent lipoatrophy. The recommended sites are the abdomen, thigh, and upper arm. I have a patient education card that shows a rotation schedule with a visual diagram. I'll send that to you along with the full training materials for your nursing staff.

That would be fantastic. Can you also do a brief in-service for my two nurses next week? I want them to be comfortable demonstrating the pen to patients.

I'd be happy to schedule that. We can do a hands-on training with demo pens. I'll also bring the patient quick-start guides in both English and Spanish since you mentioned your practice serves a bilingual population.

That's incredibly thoughtful, David. I feel much more confident about starting these patients now. Thank you for such a thorough education session.